Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States

Data from REVEAL (the first prospective, observational, noninterventional study of US patients with polycythemia vera; N=2309) confirm that many patients experience quality-of-life and work productivity impairments that may negatively impact their lives. In the future, longitudinal data from REVEAL will be important for evaluating how such burdens change over time.

Source: Clinical Lymphoma, Myeloma and Leukemia - May 28, 2018 Category: Hematology Authors: Ruben Mesa, Ralph V. Boccia, Michael R. Grunwald, Stephen T. Oh, Philomena Colucci, Dilan Paranagama, Shreekant Parasuraman, Brady L. Stein Source Type: research